| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 12.740 | 26.436 | 28.779 | 5.558 | 35.510 | 44.830 |
| Total Income - EUR | - | - | - | - | 12.740 | 26.436 | 28.779 | 5.558 | 35.510 | 48.852 |
| Total Expenses - EUR | - | - | - | - | 4.332 | 11.635 | 16.413 | 3.288 | 15.348 | 27.916 |
| Gross Profit/Loss - EUR | - | - | - | - | 8.408 | 14.801 | 12.365 | 2.271 | 20.162 | 20.936 |
| Net Profit/Loss - EUR | - | - | - | - | 8.244 | 14.556 | 12.083 | 2.215 | 19.833 | 19.753 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oncozenk S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 12 | 0 | 27 | 0 | 0 | 13.646 |
| Current Assets | - | - | - | - | 8.939 | 15.875 | 12.603 | 3.179 | 20.166 | 13.478 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 6.685 |
| Receivables | - | - | - | - | 1.818 | 4.756 | 2.383 | 444 | 3.145 | 2 |
| Cash | - | - | - | - | 7.121 | 11.118 | 10.221 | 2.735 | 17.021 | 6.792 |
| Shareholders Funds | - | - | - | - | 8.286 | 14.605 | 12.131 | 2.263 | 19.882 | 26.255 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 665 | 1.270 | 984 | 916 | 2.454 | 1.123 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncozenk S.r.l.